M1AP

Across TCGA pan-cancer cohorts, M1AP Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated M1AP data layer compared with 22 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher M1AP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated M1AP expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUAD, LIHC, and UCEC are the cancer types where M1AP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.127	0.750	<.001	18	view →
LIHC	DFS	Median	All	0.087	0.531	<.001	17	view →
UCEC	DFS	Median	II,III,IV	1.000	0.307	.016	10	view →
BLCA	OS	Median	IV	0.153	0.589	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

M1AP–LUAD (OS)

Open the LUAD breakdown →